Genetic Analysis of Innate Immunity

Advances in Immunology

Volumn 91, Issue , 2006, Pages 175-226

  Hoebe, Kasper ^a   Jiang, Zhengfan ^a   Tabeta, Koichi ^b   Du, Xin ^a   Georgel, Philippe ^c   Crozat, Karine ^a   Beutler, Bruce ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b NIIGATA UNIVERSITY   (Japan)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; CD14 ANTIGEN; CD36 ANTIGEN; CYSTEINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOLOGICAL ADJUVANT; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANTIGEN PRESENTING CELL; BACTERIUM; CELL DEATH; CELLULAR DISTRIBUTION; COMPLEX FORMATION; DRUG TOLERABILITY; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; FUNGUS; GENE MAPPING; GENE SEQUENCE; GENE STRUCTURE; GENETIC ANALYSIS; GENOME ANALYSIS; GENOTYPE PHENOTYPE CORRELATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HOST RESISTANCE; HUMAN; IMMUNOGENETICS; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; IMMUNOSTIMULATION; INFECTION; INFLAMMATORY DISEASE; INNATE IMMUNITY; MAMMAL; MENINGOCOCCEMIA; MICROORGANISM DETECTION; MOLECULAR EVOLUTION; MOLECULE; MUTAGENESIS; MUTATIONAL ANALYSIS; NONHUMAN; PHENOTYPE; PHENOTYPIC VARIATION; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW; SHOCK; SIGNAL TRANSDUCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TISSUE SPECIFICITY; TOXICITY;

ANIMALS; HUMANS; IMMUNITY, INNATE; IMMUNITY, NATURAL; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33748136556     PISSN: 00652776     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2776(06)91005-0     Document Type: Review

References (238)

1. Abumrad N.A., el Maghrabi M.R., Amri E.Z., Lopez E., and Grimaldi P.A. Cloning of a rat adipocyte membrane protein implicated in binding or transport of long-chain fatty acids that is induced during preadipocyte differentiation. Homology with human CD36. J. Biol. Chem. 268 (1993) 17665-17668
2. Adachi O., Kawai T., Takeda K., Matsumoto M., Tsutsui H., Sakagami M., Nakanishi K., and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9 (1998) 143-150
3. Adye J.C., Springer G.F., and Murthy J.R. On the nature and function of the lipopolysaccharide receptor from human erythrocytes. Z. Immunitatsforsch Exp. Klin. Immunol. 144 (1973) 491-496
4. Ahmad-Nejad P., Hacker H., Rutz M., Bauer S., Vabulas R.M., and Wagner H. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32 (2002) 1958-1968
5. Aitman T.J., Cooper L.D., Norsworthy P.J., Wahid F.N., Gray J.K., Curtis B.R., McKeigue P.M., Kwiatkowski D., Greenwood B.M., Snow R.W., Hill A.V., and Scott J. Malaria susceptibility and CD36 mutation. Nature 405 (2000) 1015-1016
6. Akashi S., Saitoh S., Wakabayashi Y., Kikuchi T., Takamura N., Nagai Y., Kusumoto Y., Fukase K., Kusumoto S., Adachi Y., Kosugi A., and Miyake K. Lipopolysaccharide interaction with cell surface Toll-like receptor 4-MD-2: Higher affinity than that with MD-2 or CD14. J. Exp. Med. 198 (2003) 1035-1042
7. Akira S., and Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 4 (2004) 499-511
8. Alexopoulou L., Holt A.C., Medzhitov R., and Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413 (2001) 732-738
9. Anderson K.V., Bokla L., and Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: The induction of polarity by the Toll gene product. Cell 42 (1985) 791-798
10. Ariizumi K., Shen G.L., Shikano S., Xu S., Ritter III R., Kumamoto T., Edelbaum D., Morita A., Bergstresser P.R., and Takashima A. Identification of a novel, dendritic cell-associated molecule, dectin-1, by subtractive cDNA cloning. J. Biol. Chem. 275 (2000) 20157-20167
11. Asch A.S., Barnwell J., Silverstein R.L., and Nachman R.L. Isolation of the thrombospondin membrane receptor. J. Clin. Invest. 79 (1987) 1054-1061
12. Bamberger M.E., Harris M.E., McDonald D.R., Husemann J., and Landreth G.E. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J. Neurosci. 23 (2003) 2665-2674
13. Barbosa M.D., Nguyen Q.A., Tchernev V.T., Ashley J.A., Detter J.C., Blaydes S.M., Brandt S.J., Chotai D., Hodgman C., Solari R.C., Lovett M., and Kingsmore S.F. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 382 (1996) 262-265
14. Bartfai T., Behrens M.M., Gaidarova S., Pemberton J., Shivanyuk A., and Rebek Jr. J. A low molecular weight mimic of the Toll/IL-1 receptor/resistance domain inhibits IL-1 receptor-mediated responses. Proc. Natl. Acad. Sci. USA 100 (2003) 7971-7976
15. Bell J.K., Botos I., Hall P.R., Askins J., Shiloach J., Segal D.M., and Davies D.R. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. USA 102 (2005) 10976-10980
16. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 (2004) 257-263
17. Beutler B. The Toll-like receptors: Analysis by forward genetic methods. Immunogenetics 57 (2005) 385-392
18. Beutler B., Krochin N., Milsark I.W., Luedke C., and Cerami A. Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance. Science 232 (1986) 977-980
19. Beutler B., Jiang Z., Georgel P., Crozat K., Croker B., Rutschmann S., Du X., and Hoebe K. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Ann. Rev. Immunol. 24 (2006) 353-389
20. Biswas C., and Mandal C. The role of amoebocytes in endotoxin-mediated coagulation in the innate immunity of Achatina fulica snails. Scand. J. Immunol. 49 (1999) 131-138
21. Bjorkbacka H., Kunjathoor V.V., Moore K.J., Koehn S., Ordija C.M., Lee M.A., Means T., Halmen K., Luster A.D., Golenbock D.T., and Freeman M.W. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10 (2004) 416-421
22. Bloksma N., Kuper C.F., Hofhuis F.M., Benaissa-Trouw B., and Willers J.M. Antitumour activity of endotoxin, concanavalin A and poly I:C and their ability to elicit tumour necrosis factor, cytostatic factors, and interferon in vivo. Cancer Immunol. Immunother. 16 (1983) 35-39
23. Bonen A., Luiken J.J., and Glatz J.F. Regulation of fatty acid transport and membrane transporters in health and disease. Mol. Cell. Biochem. 239 (2002) 181-192
24. Bright S.W., Chen T.Y., Flebbe L.M., Lei M.G., and Morrison D.C. Generation and characterization of hamster-mouse hybridomas secreting monoclonal antibodies with specificity for lipopolysaccharide receptor. J. Immunol. 145 (1990) 1-7
25. Brinkmann J.F., Abumrad N.A., Ibrahimi A., van der Vusse G.J., and Glatz J.F. New insights into long-chain fatty acid uptake by heart muscle: A crucial role for fatty acid translocase/CD36. Biochem. J. 367 (2002) 561-570
26. Brint E.K., Xu D., Liu H., Dunne A., McKenzie A.N., O'Neill L.A., and Liew F.Y. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat. Immunol. 5 (2004) 373-379
27. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S., and Gordon S. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197 (2003) 1119-1124
28. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., Wilkinson J.E., Galas D., Ziegler S.F., and Ramsdell F. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27 (2001) 68-73
29. Bultmann B., Finger H., Heymer B., Schachenmayr W., Hof H., and Haferkamp O. Adjuvancy of streptococcal nucleic acids. Z. Immunitatsforsch. Exp. Klin. Immunol. 148 (1975) 425-430
30. Burns K., Janssens S., Brissoni B., Olivos N., Beyaert R., and Tschopp J. Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4. J. Exp. Med. 197 (2003) 263-268
31. Buwitt-Beckmann U., Heine H., Wiesmüller K.H., Jung G., Brock R., Akira S., and Ulmer A.J. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur. J. Immunol. 35 (2005) 282-289
32. Calvo D., Dopazo J., and Vega M.A. The CD36, CLA-1 (CD36L1), and LIMPII (CD36L2) gene family: Cellular distribution, chromosomal location, and genetic evolution. Genome 25 (1995) 100-106
33. Calvo D., Gomez-Coronado D., Suarez Y., Lasuncion M.A., and Vega M.A. Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL. J. Lipid Res. 39 (1998) 777-788
34. Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N., Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L., et al. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 22 (1999) 231-238
35. Chaby R., Metezeau P., and Girard R. Binding of a rhodamine-labeled lipopolysaccharide to lipopolysaccharide-responder and nonresponder lymphocytes. Cell Immunol. 85 (1984) 531-541
36. Chakravarti A. Population genetics-making sense out of sequence. Nat. Genet. 21 (1999) 56-60
37. Choe J., Kelker M.S., and Wilson I.A. Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain. Science 309 (2005) 581-585
38. Clark I.A. Protection of mice against Babesia microti with cord factor, COAM, zymosan, glucan, Salmonella and Listeria. Parasite Immunol. 1 (1979) 179-196
39. Cohen J.C., Kiss R.S., Pertsemlidis A., Marcel Y.L., McPherson R., and Hobbs H.H. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305 (2004) 869-872
40. Concepcion D., Seburn K.L., Wen G., Frankel W.N., and Hamilton B.A. Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice. Genetics 168 (2004) 953-959
41. Condie R.M., Zak S.J., and Good R.A. Effect of meningococcal endotoxin on the immune response. Proc. Soc. Exp. Biol. Med. 90 (1955) 355-360
42. Coutinho A., and Meo T. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 7 (1978) 17-24
43. Coutinho A., Forni L., Melchers F., and Watanabe T. Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide. Eur. J. Immunol. 7 (1977) 325-328
44. Crozat K., Georgel P., Rutschmann S., Mann N., Du X., Hoebe K., and Beutler B. Analysis of the MCMV resistome by ENU mutagenesis. Mamm. Genome 17 5 (2006) 398-406
45. De Bouteiller O., Merck E., Hasan U.A., Hubac S., Benguigui B., Trinchieri G., Bates E.E., and Caux C. Recognition of double stranded RNA by human toll like receptor 3 and downstream receptor signaling requires multimerisation and an acidic pH. J. Biol. Chem. 280 (2005) 38133-38145
46. Diebold S.S., Kaisho T., Hemmi H., Akira S., and Reis y Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
47. El Khoury J.B., Moore K.J., Means T.K., Leung J., Terada K., Toft M., Freeman M.W., and Luster A.D. CD36 mediates the innate host response to beta-amyloid. J. Exp. Med. 197 (2003) 1657-1666
48. Elliott M.J., Maini R.N., Feldmann M., Kalden J.R., Antoni C., Smolen J.S., Leeb B., Breedveld F.C., Macfarlane J.D., Bijl H., and Woody J.N. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 344 (1994) 1105-1110
49. Elliott M.J., Maini R.N., Feldmann M., Long-Fox A., Charles P., Bijl H., and Woody J.N. Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis. Lancet 344 (1994) 1125-1127
50. Endemann G., Stanton L.W., Madden K.S., Bryant C.M., White R.T., and Protter A.A. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268 (1993) 11811-11816
51. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T., McMurray D., Smith D.E., et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413 (2001) 78-83
52. Frey E.A., Miller D.S., Jahr T.G., Sundan A., Bazil V., Espevik T., Finlay B.B., and Wright S.D. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176 (1992) 1665-1671
53. Galanos C., Luderitz O., Rietschel E.T., Westphal O., Brade H., Brade L., Freudenberg M., Schade U., Imoto M., Yoshimura H., Kusumoto S., and Shiba T. Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148 (1985) 1-5
54. Gamp A.C., Tanaka Y., Lullmann-Rauch R., Wittke D., D'Hooge R., De Deyn P.P., Moser T., Maier H., Hartmann D., Reiss K., Illert A.L., von Figura K., et al. LIMP-2/LGP85 deficiency causes ureteric pelvic junction obstruction, deafness and peripheral neuropathy in mice. Hum. Mol. Genet. 12 (2003) 631-646
55. Gantner B.N., Simmons R.M., Canavera S.J., Akira S., and Underhill D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197 (2003) 1107-1117
56. Gantner B.N., Simmons R.M., and Underhill D.M. Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J. 24 (2005) 1277-1286
57. Gay N.J., and Keith F.J. Drosophila Toll and IL-1 receptor [letter]. Nature 351 (1991) 355-356
58. Georgel P., Jiang Z., Kunz S., Hoebe K., Janssen E.M., Oldstone M.B., et al. Vesicular stomatitis virus glycoprotein G activates a specific antiviral TLR4-dependent pathway (2006) (submitted)
59. Glazier A.M., Scott J., and Aitman T.J. Molecular basis of the Cd36 chromosomal deletion underlying SHR defects in insulin action and fatty acid metabolism. Mamm. Genome 13 (2002) 108-113
60. Goodman S.A., and Morrison D.C. Lipopolysaccharide receptors on lymphocytes. I. Lack of immunologic recognition of a putative LPS receptor on LPS-responder lymphocytes by LPS-nonresponder mice. J. Immunol. 135 (1985) 1906-1910
61. Hacker H., Mischak H., Miethke T., Liptay S., Schmid R., Sparwasser T., Heeg K., Lipford G.B., and Wagner H. CpG-DNA-specific activation of antigen-presenting cells requires stress kinase activity and is preceded by non-specific endocytosis and endosomal maturation. EMBO J. 17 (1998) 6230-6240
62. Hacker H., Redecke V., Blagoev B., Kratchmarova I., Hsu L.C., Wang G.G., Kamps M.P., Raz E., Wagner H., Hacker G., Mann M., and Karin M. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439 (2006) 204-207
63. Hagberg L., Hull R., Hull S., McGhee J.R., Michalek S.M., and Svanborg Eden C. Difference in susceptibility to gram-negative urinary tract infection between C3H/HeJ and C3H/HeN mice. Infect. Immun. 46 (1984) 839-844
64. Han J., Brown T., and Beutler B. Endotoxin-responsive sequences control cachectin/TNF biosynthesis at the translational level. J. Exp. Med. 171 (1990) 465-475
65. Haranaka K., Satomi N., Sakurai A., and Haranaka R. Role of first stimulating agents in the production of tumor necrosis factor. Cancer Immunol. Immunother. 18 (1984) 87-90
66. Hawkins L.D., Ishizaka S.T., McGuinness P., Zhang H., Gavin W., DeCosta B., Meng Z., Yang H., Mullarkey M., Young D.W., Yang H., Rossignol D.P., et al. A novel class of endotoxin receptor agonists with simplified structure, toll-like receptor 4-dependent immunostimulatory action, and adjuvant activity. J. Pharmacol. Exp. Ther. 300 (2002) 655-661
67. Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., Eng J.K., Akira S., Underhill D.M., and Aderem A. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 (2001) 1099-1103
68. Haziot A., Ferrero E., Kontgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., and Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice. Immunity 4 (1996) 407-414
69. Heil F., Ahmad-Nejad P., Hemmi H., Hochrein H., Ampenberger F., Gellert T., Dietrich H., Lipford G., Takeda K., Akira S., Wagner H., and Bauer S. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33 (2003) 2987-2997
70. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., Lipford G., Wagner H., and Bauce S. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1481-1482
71. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., and Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
72. Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., Horiuchi T., Tomizawa H., Takeda K., and Akira S. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 3 (2002) 196-200
73. Heppner G., and Weiss D.W. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J. Bacteriol. 90 (1965) 696-703
74. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S., Crozat K., Tabeta K., et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signaling. Nature 424 (2003) 743-748
75. Hoebe K., Jannsen E.M., Kim S.O., Alexopoulou L., Flavell R.A., Han J., and Beutler B. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4 (2003) 1223-1229
76. Hoebe K., Georgel P., Rutschmann S., Du X., Mudd S., Crozat K., Sovath S., Shamel L., Hartung T., Zahringer U., and Beutler B. CD36 is a sensor of diacylglycerides. Nature 433 (2005) 523-527
77. Horng T., Barton G.M., and Medzhitov R. TIRAP: An adapter molecule in the Toll signaling pathway. Nat. Immunol. 2 (2001) 835-841
78. Horuk R., Chitnis C.E., Darbonne W.C., Colby T.J., Rybicki A., Hadley T.J., and Miller L.H. A receptor for the malarial parasite Plasmodium vivax: The erythrocyte chemokine receptor. Science 261 (1993) 1182-1184
79. Huber M., Kalis C., Keck S., Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Beutler B., Galanos C., and Freudenberg M.A. R-form LPS, the master key to the activation of TLR4/MD2 positive cells. Eur. J. Immunol. 36 (2006) 701-711
80. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., Olson J.M., Lee J.C., Beaugerie L., Naom I., Dupas J.L., Van Gossum A., Orholm M., Bonaiti-Pellie C., Weissenbach J., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome16. Nature 379 (1996) 821-823
81. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., Binder V., Finkel Y., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411 (2001) 599-603
82. Ibrahimi A., Sfeir Z., Magharaie H., Amri E.Z., Grimaldi P., and Abumrad N.A. Expression of the CD36 homolog (FAT) in fibroblast cells: Effects on fatty acid transport. Proc. Natl. Acad. Sci. USA 93 (1996) 2646-2651
83. Imoto M., Yoshimura H., Kusumoto S., and Shiba T. Total synthesis of lipid A, active principle of bacterial endotoxin. Proc. Jpn. Acad. Sci. 60 (1984) 285-288
84. Inohara N., Chamaillard M., McDonald C., and Nunez G. NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Annu. Rev. Biochem. 74 (2005) 355-383
85. Ishii K.J., Coban C., Kato H., Takahashi K., Torii Y., Takeshita F., Ludwig H., Sutter G., Suzuki K., Hemmi H., Sato S., Yamamoto M., et al. A Toll-like receptor-independent antiviral response induced by double-stranded B-form DNA. Nat. Immunol. 7 (2006) 40-48
86. Jacobs D.M., and Eldridge J.H. Surface phenotype of LPS-binding murine lymphocytes. Proc. Soc. Exp. Biol. Med. 175 (1984) 458-467
87. Janeway Jr. C.A. Approaching the asymptote? Evolution and revolution in immunology 20. Cold Spring Harb. Symp. Quant. Biol. 54 Pt. 1 (1989) 1-13
88. Janssen E.M., Tabeta K., Barnes M., Rutschmann S., McBride S., Bahjat K., Schoenberger S.P., Theoflopoulos A.N., Beutler B., and Hoebe K. Efficient T cell activation via a Toll-Interleukin I receptor-independent pathway. Immunity (2006) (in press)
89. Janssens S., Burns K., Vercammen E., Tschopp J., and Beyaert R. MyD88S, a splice variant of MyD88, differentially modulates NF-kappaB- and AP-1-dependent gene expression. FEBS Lett. 548 (2003) 103-107
90. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., Freudenberg M., and Beutler B. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 6 (2005) 565-570
91. Jiang Z., Georgel P., Li C., Choe J., Crozat K., Rutschmann S., Du X., Bigby T., Mudd S., Sovath S., Wilson I.A., Olson A., et al. Details of Toll-like receptor:adapter interaction revealed by germline mutagenesis. Proc. Natl. Acad. Sci. USA (2006) in press
92. Jude B.A., Pobezinskaya Y., Bishop J., Parke S., Medzhitov R.M., Chervonsky A.V., and Golovkina T.V. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4 (2003) 573-578
93. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., Lipford G., and Bauer S. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3 (2002) 499
94. Justice M.J., Noveroske J.K., Weber J.S., Zheng B., and Bradley A. Mouse ENU mutagenesis. Hum. Mol. Genet. 8 (1999) 1955-1963
95. Kashiwagi H., Tomiyama Y., Kosugi S., Shiraga M., Lipsky R.H., Kanayama Y., Kurata Y., and Matsuzawa Y. Identification of molecular defects in a subject with type I CD36 deficiency. Blood 83 (1994) 3545-3552
96. Kashiwagi H., Tomiyama Y., Honda S., Kosugi S., Shiraga M., Nagao N., Sekiguchi S., Kanayama Y., Kurata Y., and Matsuzawa Y. Molecular basis of CD36 deficiency. Evidence that a 478C→T substitution (proline90→serine) in CD36 cDNA accounts for CD36 deficiency. J. Clin. Invest. 95 (1995) 1040-1046
97. Kashiwagi H., Tomiyama Y., Kosugi S., Shiraga M., Lipsky R.H., Nagao N., Kanakura Y., Kurata Y., and Matsuzawa Y. Family studies of type II CD36 deficient subjects: Linkage of a CD36 allele to a platelet-specific mRNA expression defect(s) causing type II CD36 deficiency. Thromb. Haemost. 74 (1995) 758-763
98. Kashiwagi H., Tomiyama Y., Nozaki S., Honda S., Kosugi S., Shiraga M., Nakagawa T., Nagao N., Kanakura Y., Kurata Y., and Matsuzawa Y. A single nucleotide insertion in codon 317 of the CD36 gene leads to CD36 deficiency. Arterioscler Thromb. Vasc. Biol. 16 (1996) 1026-1032
99. Kawai T., and Akira S. Innate immune recognition of viral infection. Nat. Immunol. 7 (2006) 131-137
100. Kawai T., Takeuchi O., Fujita T., Inoue J., Muhlradt P.F., Sato S., Hoshino K., and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167 (2001) 5887-5894
101. Kawai T., Takahashi K., Sato S., Coban C., Kumar H., Kato H., Ishii K.J., Takeuchi O., and Akira S. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 6 (2005) 981-988
102. Kawata T., Bristol J.R., Rossignol D.P., Rose J.R., Kobayashi S., Yokohama H., Ishibashi A., Christ W.J., Katayama K., Yamatsu I., and Kishi Y. E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide. Br. J. Pharmacol. 127 (1999) 853-862
103. Khan J.A., Brint E.K., O'Neill L.A., and Tong L. Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL. J. Biol. Chem. 279 (2004) 31664-31670
104. Kile B.T., Hentges K.E., Clark A.T., Nakamura H., Salinger A.P., Liu B., Box N., Stockton D.W., Johnson R.L., Behringer R.R., Bradley A., and Justice M.J. Functional genetic analysis of mouse chromosome 11. Nature 425 (2003) 81-86
105. Kim J.I., Lee C.J., Jin M.S., Lee C.H., Paik S.G., Lee H., and Lee J.O. Crystal structure of CD14 and its implications for lipopolysaccharide signaling. J. Biol. Chem. 280 (2005) 11347-11351
106. Kinjyo I., Hanada I., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., and Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 17 (2002) 583-591
107. Kirikae T., Kirikae F., Schade F.U., Yoshida M., Kondo S., Hisatsune K., Nishikawa S., and Rietschel E.T. Detection of lipopolysaccharide-binding proteins on membranes of murine lymphocyte and macrophage-like cell lines. FEMS Microbiol. Immunol. 3 (1991) 327-336
108. Kirkland T.N., Virca G.D., Kuus-Reichel T., Multer F.K., Kim S.Y., Ulevitch R.J., and Tobias P.S. Identification of lipopolysaccharide-binding proteins in 70Z/3 cells by photoaffinity cross-linking. J. Biol. Chem. 265 (1990) 9520-9525
109. Kobayashi K., Hernandez L.D., Galan J.E., Janeway Jr. C.A., Medzhitov R., and Flavell R.A. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110 (2002) 191-202
110. Kobayashi K.S., Chamaillard M., Ogura Y., Henegariu O., Inohara N., Nunez G., and Flavell R.A. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
111. Kobe B., and Deisenhofer J. Crystal structure of porcine ribonuclease inhibitor, a protein with leucine-rich repeats. Nature 366 (1993) 751-756
112. Kobe B., and Deisenhofer J. A structural basis of the interactions between leucine-rich repeats and protein ligands. Nature 374 (1995) 183-186
113. Kruys V., Thompson P., and Beutler B. Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway. J. Exp. Med. 177 (1993) 1383-1390
114. Kunjathoor V.V., Febbraio M., Podrez E.A., Moore K.J., Andersson L., Koehn S., Rhee J.S., Silverstein R., Hoff H.F., and Freeman M.W. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J. Biol. Chem. 277 (2002) 49982-49988
115. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., and Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1 (2000) 398-401
116. Lander E.S. The new genomics: Global views of biology. Science 274 (1996) 536-539
117. Le Bon A., and Tough D.F. Links between innate and adaptive immunity via type I interferon. Curr. Opin. Immunol. 14 (2002) 432-436
118. Le Bon A., Schiavoni G., D'Agostino G., Gresser I., Belardelli F., and Tough D.F. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14 (2001) 461-470
119. Leadbetter E.A., Rifkin I.R., Hohlbaum A.M., Beaudette B.C., Shlomchik M.J., and Marshak-Rothstein A. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416 (2002) 603-607
120. Leadbetter E.A., Rifkin I.R., and Marshak-Rothstein A. Toll-like receptors and activation of autoreactive B cells. Curr. Dir. Autoimmun. 6 (2003) 105-122
121. Lee J., Chuang T.H., Redecke V., She L., Pitha P.M., Carson D.A., Raz E., and Cottam H.B. Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: Activation of Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 100 (2003) 6646-6651
122. Lee J.D., Kato K., Tobias P.S., Kirkland T.N., and Ulevitch R.J. Transfection of CD14 into 70Z/3 cells dramatically enhances the sensitivity to complexes of lipopolysaccharide (LPS) and LPS binding protein. J. Exp. Med. 175 (1992) 1697-1705
123. Lee J.-D., Kravchenko V., Kirkland T.N., Han J., Mackman N., Moriarty A., Leturcq D., Tobias P.S., and Ulevitch R.J. Glycosyl-phosphatidylinositol-anchored or integral membrane forms of CD14 mediate identical cellular responses to endotoxin. Proc. Natl. Acad. Sci. USA 90 (1993) 9930-9934
124. Lei M.G., and Morrison D.C. Specific endotoxic lipopolysaccharide-binding proteins on murine splenocytes. I. Detection of lipopolysaccharide-binding sites on splenocytes and splenocyte subpopulations. J. Immunol. 141 (1988) 996-1005
125. Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., and Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86 (1996) 973-983
126. Li C., Zienkiewicz J., and Hawiger J. Interactive sites in the MyD88 Toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1beta signaling pathway. J. Biol. Chem. 280 (2005) 26152-26159
127. Li W., Rusiniak M.E., Chintala S., Gautam R., Novak E.K., and Swank R.T. Murine Hermansky-Pudlak syndrome genes: Regulators of lysosome-related organelles. BioEssays 26 (2004) 616-628
128. Lien E., Means T.K., Heine H., Yoshimura A., Kusumoto S., Fukase K., Fenton M.J., Oikawa M., Qureshi N., Monks B., Finberg R.W., Ingalls R.R., et al. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105 (2000) 497-504
129. Lord K.A., Hoffman-Liebermann B., and Liebermann D.A. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5 (1990) 1095-1097
130. Luderitz O., Galanos C., Lehmann V., Nurminen M., Rietschel E.T., Rosenfelder G., Simon M., and Westphal O. Lipid A: Chemical structure and biological activity. J. Infect. Dis. 128 (1973) 29
131. Lund J.M., Alexopoulou L., Sato A., Karow M., Adams N.C., Gale N.W., Iwasaki A., and Flavell R.A. Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101 (2004) 5598-5603
132. MacFarlane D.E., and Manzel L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160 (1998) 1122-1131
133. Mains P.E., and Sibley C.H. LPS-nonresponsive variants of mouse B cell lymphoma, 70Z/3: Isolation and characterization. Somatic Cell Genet. 9 (1983) 699-720
134. Manukyan M., Triantafilou K., Triantafilou M., Mackie A., Nilsen N., Espevik T., Wiesmuller K.H., Ulmer A.J., and Heine H. Binding of lipopeptide to CD14 induces physical proximity of CD14, TLR2 and TLR1. Eur. J. Immunol. 35 (2005) 911-921
135. Manzel L., Strekowski L., Ismail F.M., Smith J.C., and MacFarlane D.E. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by 4-aminoquinolines and other weak bases: Mechanistic studies. J. Pharmacol. Exp. Ther. 291 (1999) 1337-1347
136. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., Yamamoto A., and Seya T. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J. Immunol. 171 (2003) 3154-3162
137. Matzinger P. Essay 1: The danger model in its historical context. Scand. J. Immunol. 54 (2001) 4-9
138. Matzinger P. Introduction to the series. Danger model of immunity. Scand. J. Immunol. 54 (2001) 2-3
139. Matzinger P. The danger model: A renewed sense of self. Science 296 (2002) 301-305
140. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity [AUee comments]. Nature 388 (1997) 394-397
141. Meng G., Grabiec A., Vallon M., Ebe B., Hampel S., Bessler W., Wagner H., and Kirschning C.J. Cellular recognition of tri-/di-palmitoylated peptides is independent from a domain encompassing the N-terminal seven leucine-rich repeat (LRR)/LRR-like motifs of TLR2. J. Biol. Chem. 278 (2003) 39822-39829
142. Meylan E., Burns K., Hofmann K., Blancheteau V., Martinon F., Kelliher M., and Tschopp J. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-kappa B activation. Nat. Immunol. 5 (2004) 503-507
143. Meylan E., Curran J., Hofmann K., Moradpour D., Binder M., Bartenschlager R., and Tschopp J. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437 (2005) 1167-1172
144. Michalek S.M., Moore R.N., McGhee J.R., Rosenstreich D.L., and Mergenhagen S.E. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J. Infec. Dis. 141 (1980) 55-63
145. Mink M., Fogelgren B., Olszewski K., Maroy P., and Csiszar K. A novel human gene (SARM) at chromosome 17q11 encodes a protein with a SAM motif and structural similarity to Armadillo/beta-catenin that is conserved in mouse, Drosophila, and Caenorhabditis elegans 2. Genomics 74 (2001) 234-244
146. Miura Y., Miyake K., Yamashita Y., Shimazu R., Copeland N.G., Gilbert D.J., Jenkins N.A., Inazawa J., Abe T., and Kimoto M. Molecular cloning of a human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genome 38 (1996) 299-304
147. Miyake K., Yamashita Y., Ogata M., Sudo T., and Kimoto M. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol. 154 (1995) 3333-3340
148. Moore K.J., El Khoury J., Medeiros L.A., Terada K., Geula C., Luster A.D., and Freeman M.W. A CD36-initiated signaling cascade mediates inflammatory effects of beta-amyloid. J. Biol. Chem. 277 (2002) 47373-47379
149. Morr M., Takeuchi O., Akira S., Simon M.M., and Muhlradt P.F. Differential recognition of structural details of bacterial lipopeptides by toll-like receptors. Eur. J. Immunol. 32 (2002) 3337-3347
150. Nachman M.W., and Crowell S.L. Estimate of the mutation rate per nucleotide in humans. Genetics 156 (2000) 297-304 (in process citation)
151. Nagai Y., Akashi S., Nagafuku M., Ogata M., Iwakura Y., Akira S., Kitamura T., Kosugi A., Kimoto M., and Miyake K. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3 (2002) 667-672
152. Nagamine K., Peterson P., Scott H.S., Kudoh J., Minoshima S., Heino M., Krohn K.J., Lalioti M.D., Mullis P.E., Antonarakis S.E., Kawasaki K., Asakawa S., et al. Positional cloning of the APECED gene. Nat. Genet. 17 (1997) 393-398
153. Ninomiya-Tsuji J., Kishimoto K., Hiyama A., Inoue J., Cao Z., and
154. Nishiya T., and DeFranco A.L. Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the toll-like receptors. J. Biol. Chem. 279 (2004) 19008-19017
155. Nishiya T., Kajita E., Miwa S., and DeFranco A.L. TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J. Biol. Chem. 280 (2005) 37107-37117
156. Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S., Nagase T., Seki N., Ishikawa K., and Tabata S. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res. 1 (1994) 27-35
157. Norledge B.V., Petrovan R.J., Ruf W., and Olson A.J. The tissue factor/factor VIIa/factor Xa complex: A model built by docking and site-directed mutagenesis. Proteins 53 (2003) 640-648
158. Nozaki S., Kashiwagi H., Yamashita S., Nakagawa T., Kostner B., Tomiyama Y., Nakata A., Ishigami M., Miyagawa J., and Kameda-Takemura K. Reduced uptake of oxidized low density lipoproteins in monocyte-derived macrophages from CD36-deficient subjects. J. Clin. Invest. 96 (1995) 1859-1865
159. Nygren H., Dahlen G., and Moller G. Bacterial lipopolysaccharides bind selectively to lymphocytes from lipopolysaccharide high-responder mouse strains. Scand. J. Immunol. 10 (1979) 555-561
160. O'Brien A.D., Rosenstreich D.L., Scher I., Campbell G.H., MacDermott R.P., and Formal S.B. Genetic control of susceptibility to Salmonella typhimurium in mice: Role of the LPS gene. J. Immunol. 124 (1980) 20-24
161. Ogata H., Su l., Miyake K., Nagai Y., Akashi S., Mecklenbrauker I., Rajewsky K., Kimoto M., and Tarakhovsky A. The toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192 (2000) 23-30 (in process citation)
162. Ogawa S., Lozach J., Benner C., Pascual G., Tangirala R.K., Westin S., Hoffmann A., Subramaniam S., David M., Rosenfeld M.G., and Glass C.K. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell 122 (2005) 707-721
163. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., Achkar J.P., Brant S.R., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411 (2001) 603-606
164. Okabe Y., Kawane K., Akira S., Taniguchi T., and Nagata S. Toll-like receptor-independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J. Exp. Med. 202 (2005) 1333-1339
165. Ortega-Cava C.F., Ishihara S., Rumi M.A., Kawashima K., Ishimura N., Kazumori H., Udagawa J., Kadowaki Y., and Kinoshita Y. Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J. Immunol. 170 (2003) 3977-3985
166. Oshiumi H., Matsumoto M., Funami K., Akazawa T., and Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4 (2003) 161-171
167. Oshiumi H., Sasai M., Shida K., Fujita T., Matsumoto M., and Seya T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta. J. Biol. Chem. 278 (2003) 49751-49762
168. Pancer Z., Amemiya C.T., Ehrhardt G.R., Ceitlin J., Gartland G.L., and Cooper M.D. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430 (2004) 174-180
169. Perry W.L., Hustad C.M., Swing D.A., O'Sullivan T.N., Jenkins N.A., and Copeland N.G. The itchy locus encodes a novel ubiquitin protein ligase that is disrupted in a18H mice. Nat. Genet. 18 (1998) 143-146
170. Pfeiffer A., Bottcher A., Orso E., Kapinsky M., Nagy P., Bodnar A., Spreitzer I., Liebisch G., Drobnik W., Gempel K., Horn M., Holmer S., et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand-specific receptor clustering in rafts. Eur. J. Immunol. 31 (2001) 3153-3164
171. Pfeiffer R. Untersuchungen über das Choleragift. Z Hygiene 11 (1892) 393-412
172. Poltorak A., He X., Smirnova I., Liu M.-Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M.A., Ricciardi-Castagnoli P., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282 (1998) 2085-2088
173. Poltorak A., Ricciardi-Castagnoli P., Citterio A., and Beutler B. Physical contact between LPS and Tlr4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA 97 (2000) 2163-2167
174. Poltorak A., Smirnova I., Clisch R., and Beutler B. Limits of a deletion spanning Tlr4 in C57BL/10ScCr mice. J. Endotoxin Res. 6 (2000) 51-56
175. Rehli M., Poltorak A., Schwarzfischer L., Krause S.W., Andreesen R., and Beutler B. PU.1 and interferon consensus sequence binding protein (ICSBP) regulate the myeloid expression of the human Toll-like receptor 4 gene. J. Biol. Chem. 275 (2000) 9773-9781
176. Rigotti A., Acton S.L., and Krieger M. The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. J. Biol. Chem. 270 (1995) 16221-16224
177. Rioux J.D., Daly M.J., Silverberg M.S., Lindblad K., Steinhart H., Cohen Z., Delmonte T., Kocher K., Miller K., Guschwan S., Kulbokas E.J., O'Leary S., et al. Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat. Genet. 29 (2001) 223-228
178. Rosenstreich D.L., Weinblatt A.C., and O'Brien A.D. Genetic control of resistance to infection in mice. CRC Crit. Rev. Immunol. 3 (1982) 263-330
179. Rothenfusser S., Goutagny N., Diperna G., Gong M., Monks B.G., Schoenemeyer A., Yamamoto M., Akira S., and Fitzgerald K.A. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. J. Immunol. 175 (2005) 5260-5268
180. Royer-Pokora B., Kunkel L.M., Monaco A.P., Goff S.C., Newburger P.E., Baehner R.L., Cole F.S., Curnutte J.T., and Orkin S.H. Cloning the gene for an inherited human disorder-chronic granulomatous disease-on the basis of its chromosomal location. Nature 322 (1986) 32-38
181. Russo M., and Lutton J.D. Decreased in vivo and in vitro colony stimulating activity responses to bacterial lipopolysaccharide in C3H/HeJ mice. J. Cell. Physiol. 92 (1977) 303-307
182. Rutschmann S., Hoebe K., Zalevsky J., Du X., Mann N., Dahiyat B.I., Steed P., and Beutler B. PanR1, a dominant negative missense allele of Tumor Necrosis Factor-alpha, does not impair lymphoid development. J. Immunol. 176 (2006) 7525-7532
183. Rutz M., Metzger J., Gellert T., Luppa P., Lipford G.B., Wagner H., and Bauer S. Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner. Eur. J. Immunol. 34 (2004) 2541-2550
184. Sato M., Sano H., Iwaki D., Kudo K., Konishi M., Takahashi H., Takahashi T., Imaizumi H., Asai Y., and Kuroki Y. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J. Immunol. 171 (2003) 417-425
185. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., Zurawski G., Moshrefi M., Qin J., Li X., Gorman D.M., Bazan J.F., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23 (2005) 479-490
186. Schroder N.W., Morath S., Alexander C., Hamann L., Hartung T., Zahringer U., Gobel U.B., Weber J.R., and Schumann R.R. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem. 278 (2003) 15587-15594
187. Schupbach T., and Wieschaus E. Germline autonomy of maternal-effect mutations altering the embryonic body pattern of Drosophila. Dev. Biol. 113 (1986) 443-448
188. Seth R.B., Sun L., Ea C.K., and Chen Z.J. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122 (2005) 669-682
189. Shakhov A.N., Collart M.A., Vassalli P., Nedospasov S.A., and Jongeneel C.V. KappaB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med. 171 (1990) 35-47
190. Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., and Kimoto M. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189 (1999) 1777-1782
191. Silverstein R.L., Asch A.S., and Nachman R.L. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J. Clin. Invest. 84 (1989) 546-552
192. Sioud M. Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization. J. Mol. Biol. 348 (2005) 1079-1090
193. Skidmore B.J., Chiller J.M., Morrison D.C., and Weigle W.O. Immunologic properties of bacterial lipopolysaccharide (LPS): Correlation between the mitogenic, adjuvant, and immunogenic activities. J. Immunol. 114 (1975) 770-775
194. Smirnova I., Poltorak A., Chan E.K.L., McBride C., and Beutler B. Phylogenetic variation and polymorphism at the Toll-like receptor 4 locus (TLR4). Genome Biol. 1 (2000) 1-10
195. Smirnova I., Hamblin M., McBride C., Beutler B., and Di Rienzo A. Excess of rare amino acid polymorphisms in the Toll-like receptor 4 in humans. Genetics 158 (2001) 1657-1664
196. Smirnova I., Mann N., Dols A., Derkx H.H., Hibberd M.L., Levin M., and Beutler B. Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility. Proc. Natl. Acad. Sci. USA 100 (2003) 6075-6080
197. Smith K.D., Andersen-Nissen E., Hayashi F., Strobe K., Bergman M.A., Barrett S.L., Cookson B.T., and Aderem A. Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat. Immunol. 4 (2003) 1247-1253
198. Springer G.F., and Adye J.C. Endotoxin-binding substances from human leukocytes and platelets. Infect. Immun. 12 (1975) 978-986
199. Springer G.F., Adye J.C., Bezkorovainy A., and Murthy J.R. Functional aspects and nature of the lipopolysaccharide-receptor of human erythrocytes. J. Infect. Dis. 128 Suppl. (1973) S202-S212
200. Springer G.F., Adye J.C., Bezkorovainy A., and Jirgensons B. Properties and activity of the lipopolysaccharide-receptor from human erythrocytes. Biochemistry 13 (1974) 1379-1389
201. Steinberg M.H. Sickle cell anaemia in a septuagenarian. Br. J. Haematol. 71 (1989) 297-298
202. Steinberg M.H. Modulation of the phenotypic diversity of sickle cell anemia. Hemoglobin 20 (1996) 1-19
203. Steinberg M.H. Predicting clinical severity in sickle cell anaemia. Br. J. Haematol. 129 (2005) 465-481
204. Tabeta K., Georgel P., Janssen E., Du X., Hoebe K., Crozat K., Mudd S., Shamel L., Sovath S., Goode J., Alexopoulou L., Flavell R.A., et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101 (2004) 3516-3521
205. Tabeta K., Hoebe K., Jannsen E.M., Du X., Georgel P., Crozat K., Mudd S., Mann N., Sovath S., Goode J., Shamel L., Herskovitz A.A., et al. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7, and 9. Nat. Immunol. 7 (2006) 156-164
206. Taguchi T., Mitcham J.L., Dower S.K., Sims J.E., and Testa J.R. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genome 32 (1996) 486-488
207. Takaesu G., Surabhi R.M., Park K.J., Ninomiya-Tsuji J., Matsumoto K., and Gaynor R.B. TAK1 is critical for IkappaB kinase-mediated activation of the NF-kappaB pathway. J. Mol. Biol. 326 (2003) 105-115
208. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S., Honda K., Ohba Y., Mak T.W., and Taniguchi T. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434 (2005) 243-249
209. Takayama K., Qureshi N., and Mascagni P. Complete structure of lipid A obtained from the lipopolysaccharides of the heptoseless mutant of Salmonella typhimurium. J. Biol. Chem. 258 (1983) 12801-12803
210. Takeuchi O., Kaufmann A., Grote K., Kawai T., Hoshino K., Morr M., Mühlradt P.F., and Akira S. Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164 (2000) 554-557
211. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., Takeda K., and Akira S. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int. Immunol. 13 (2001) 933-940
212. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., Modlin R.L., and Akira S. Cutting edge: Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J. Immunol. 169 (2002) 10-14
213. Tao X., Xu Y., Zheng Y., Beg A.A., and Tong L. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. Biochem. Biophys. Res. Commun. 299 (2002) 216-221
214. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., and Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195 (2002) 99-111
215. The Finnish-German, APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Autoimmune polyendocrinopathy-Candidiasis-ectodermal dystrophy. Nat. Genet. 17 (1997) 399-403
216. Tsuji K., and Harrison S.J. Limulus amebocyte lysate-a means to monitor inactivation of lipopolysaccharide. Prog. Clin. Biol. Res. 29 (1979) 367-378
217. Tuszynski G.P., Karczewski J., Smith L., Murphy A., Rothman V.L., and Knudsen K.A. The GPIIB-IIIa-like complex may function as a human melanoma cell adhesion receptor for thrombospondin. Exp. Cell. Res. 182 (1989) 473-481
218. Underhill D.M., Ozinsky A., Hajjar A.M., Stevens A., Wilson C.B., Bassetti M., and Aderem A. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens [see comments]. Nature 401 (1999) 811-815
219. Urushizaki I., Niitsu Y., and Watanabe N. Definition of tumor-necrosis factor and its production mechanism. Gan To Kagaku Ryoho 11 (1984) 1356-1368
220. Viglianti G.A., Lau C.M., Hanley T.M., Miko B.A., Shlomchik M.J., and Marshak-Rothstein A. Activation of autoreactive B cells by CpG dsDNA. Immunity 19 (2003) 837-847
221. Vinuesa C.G., Cook M.C., Angelucci C., Athanasopoulos V., Rui L., Hill K.M., Yu D., Domaschenz H., Whittle B., Lambe T., Roberts I.S., Copley R.R., et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435 (2005) 452-458
222. Wald D., Qin J., Zhao Z., Qian Y., Naramura M., Tian L., Towne J., Sims J.E., Stark G.R., and Li X. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4 (2003) 920-927
223. Washida S. Endotoxin receptor site. I. Binding of endotoxin to platelets. Acta Med. Okayama 32 (1978) 159-167
224. Washida S. Endotoxin receptor site. II. Specificity of endotoxin receptor of platelets and sensitivity to endotoxin in vivo. Acta Med. Okayama 32 (1978) 217-223
225. Watson J., Kelly K., Largen M., and Taylor B.A. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J. Immunol. 120 (1978) 422-424
226. Wesche H., Henzel W.J., Shillinglaw W., Li S., and Cao Z. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex. Immunity 7 (1997) 837-847
227. Wright A.F., Carothers A.D., and Pirastu M. Population choice in mapping genes for complex diseases. Nat. Genet. 23 (1999) 397-404
228. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., and Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 (1990) 1431-1433
229. Xu L.G., Wang Y.Y., Han K.J., Li L.Y., Zhai Z., and Shu H.B. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19 (2005) 727-740
230. Xu Y., Tao X., Shen B., Horng T., Medzhitov R., Manley J.L., and Tong L. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408 (2000) 111-115
231. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T., Takeda K., and Akira S. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature 420 (2002) 324-329
232. Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., and Akira S. Cutting edge: A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J. Immunol. 169 (2002) 6668-6672
233. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., and Akira S. Role of adapter TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 301 (2003) 640-643
234. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K., and Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat. Immunol. 4 (2003) 1144-1150
235. Yamamoto N., Akamatsu N., Sakuraba H., Yamazaki H., and Tanoue K. Platelet glycoprotein IV (CD36) deficiency is associated with the absence (type I) or the presence (type II) of glycoprotein IV on monocytes. Blood 83 (1994) 392-397
236. Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., Hieny S., Sutterwala F.S., Flavell R.A., Ghosh S., and Sher A. TLR11 Activation of dendritic cells by a protozoan profilin-like protein. Science 308 (2005) 1626-1629
237. Yauch L.E., Mansour M.K., Shoham S., Rottman J.B., and Levitz S.M. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect. Immun. 72 (2004) 5373-5382
238. Yoneyama M., Kikuchi M., Matsumoto K., Imaizumi T., Miyagishi M., Taira K., Foy E., Loo Y.M., Gale Jr. M., Akira S., Yonehara S., Kato A., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J. Immunol. 175 (2005) 2851-2858